Stay updated on Seagen Press Releases

Sign up to get notified when there's something new on the Seagen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Seagen Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    The press release list now features FDA approval of Pfizer’s TUKYSA regimen as front-line maintenance treatment for HER2-positive metastatic breast cancer, along with the company’s fourth-quarter 2026 dividend announcement. Earlier releases about TALZENNA’s priority review and EU authorization of an adapted COVID-19 vaccine are no longer listed.
    Difference
    4%
    Check dated 2026-10-13T03:50:17.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The listings now include October 2026 research updates on LITFULO and tilrekimig, with related Research and Pipeline categories. The Pfizer dividend announcement and a PADCEV/Keytruda FDA approval release are no longer listed.
    Difference
    4%
    Check dated 2026-10-05T19:55:20.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The Press Releases list now includes a November 3 conference call webcast invitation and a new ESMO-related release, while the August 4 conference call invitation and the June 24 FDA/IBRANCE release have been removed.
    Difference
    3%
    Check dated 2026-09-28T20:47:04.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The Press Releases page adds Finance and Financial categories and introduces a new item inviting the public to listen to a Pfizer conference webcast on 09.15.2026, while the Research and Pipeline category is removed and a June 22, 2026 Sigvotatug Vedotin press release is deleted.
    Difference
    2%
    Check dated 2026-09-21T21:53:09.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A Finance category was added and a new press release inviting the public to listen to Pfizer's webcast (dated 09.08.2026) was added to the September 2026 listings. A prior press release about the Chief Financial Officer transition (June 18, 2026) under Leadership/Corporate was removed.
    Difference
    2%
    Check dated 2026-09-14T18:58:29.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Adds the Covid-19 and Vaccines categories and publishes a new press release announcing the FDA approval of the XFG-adapted COVID-19 vaccine (08.27.2026). Removes the Medicines and Prescription Medicines categories and deletes the HYMPAVZI press release dated 06.08.2026.
    Difference
    2%
    Check dated 2026-08-31T18:53:50.000Z thumbnail image

Stay in the know with updates to Seagen Press Releases

Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.